Our Katherine Heinze, Heidi Holtz and Cynda Rushton write, “Palliative care (PC) clinicians are faced with ever-expanding pressures, which can make it difficult to fulfill their duties to self and others and lead to moral distress.”

Quick Read

“Death with dignity” has meant, for many people, avoiding unwanted medical technology and dying in a hospital. A “natural” death has been the goal. In the past 20 years, physician-assisted suicide has been legalized for terminally ill patients in several states of the US, and recently “medical assistance in dying,” has become legal in Canada. How should we think about what constitutes a good death now?

Quick Read

Doctors who tend to spend more in treating hospitalized patients do not get better results than those who spend less, a new study has found

Quick Read

Gerald Chinchar isn’t quite at the end of life, but the end is not far away. The 77-year-old fell twice last year, shattering his hip and femur, and now gets around his San Diego home in a wheelchair. His medications fill a dresser drawer, and congestive heart failure puts him at high risk of emergency room visits and long hospital stays

Quick Read

Politicians and policymakers are discussing what parts of the Affordable Care Act to change and what to keep. While most of us have little control over those discussions, there is one health care topic that we can control: what we talk about with our doctor

Quick Read

Loneliness can be a problem for older people, especially when they’re in the hospital. Their children may have moved away. Spouses and friends may themselves be too frail to visit. So a California hospital is providing volunteer companions in the geriatric unit

Quick Read

Tiny particles of pollution have been discovered inside samples of brain tissue, according to new research

Quick Read

The hammer has finally dropped on blood-testing startup Theranos and its beleaguered CEO Elizabeth Holmes. US federal health regulators have announced their decision to ban Holmes from operating a lab for two years, while withdrawing regulatory approval for its California lab

Quick Read